# LEMAITRE VASCULAR, INC. (LMAT) FY2026 YTD Q2 P&L / Income Statement

- Company: LEMAITRE VASCULAR, INC. (LMAT)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001193125-26-333762
- Page: https://plicit.ai/financials/lmat/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/lmat-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 136,933,000 US dollars
- **Cost of sales**: 37,773,000 US dollars
- **Gross profit**: 99,160,000 US dollars
- **Total operating expenses**: 60,986,000 US dollars
- **Income from operations**: 38,174,000 US dollars
- **Other income (expense), net (calculated)**: 3,687,000 US dollars
- **Income before income taxes**: 41,861,000 US dollars
- **Provision for income taxes**: 9,132,000 US dollars
- **Net income**: 32,729,000 US dollars
- **UNITED STATES**: 75,436,000 US dollars
- **GERMANY**: 10,879,000 US dollars
- **CANADA**: 8,604,000 US dollars
- **UNITED KINGDOM**: 6,851,000 US dollars
- **Other countries**: 35,163,000 US dollars
- **General and administrative**: 23,156,000 US dollars
- **Research and development**: 8,907,000 US dollars
- **Sales and marketing**: 28,923,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.